Regulatory interventions related to the disruptive effects of the pandemic from Covid-19 offer the opportunity to attribute greater values to the assets of the company, with capital benefits and the possibility of tax recognition.

But what reflections should be made to face this passage with awareness? How to behave towards immaterial activities?

What concrete objectives must the company set itself and what reading will the financial stakeholders give?